World Congress on Nanomedicine 2026 Opens in New Delhi

The World Congress on Nanomedicine 2026 was inaugurated at Vigyan Bhawan, New Delhi, on 27 September 2026 by Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology and Earth Sciences. He told the gathering that nanomedicine will carry forward the next stage of precision medicine and personalised healthcare, and that research done within India has worldwide value.

Who is hosting it

The congress is hosted by the Institute of Nano Medical Sciences (INMS) of the Faculty of Medical Sciences, University of Delhi, and runs under the umbrella of the International Society of Nano Medical Sciences and the International Society for Nano Medicine. More than 2,000 participants, among them senior scientists and young researchers, are taking part.

Who is leading the congress

Prof. Gobardhan Das, a Member of NITI Aayog, along with Prof. G. P. Talwar, Prof. Ramesh Chandra and Prof. Indrajit Roy, attended the opening session. Prof. Kornberg called the field young and fast moving, saying its promise lies in placing the right quantity of a medicine at the right spot at the right moment, so that treatment works better and poisons the body less.

What the government is funding

• The Department of Biotechnology is supporting 210 research and development projects in nanomedicine with Rs 174 crore.
• The projects span targeted drug delivery, cancer nanomedicine, infectious-disease nanomedicine, nucleic-acid and vaccine delivery, nano-diagnostics and imaging, regenerative medicine, wound healing, nanotoxicology and regulatory science.
• Promising Indian work includes oral insulin nanoparticles, nanobots aimed at breast cancer and precision nanoinjection.
• Through BIRAC, young firms can draw on the Biotechnology Ignition Grant, PACE, the Small Business Innovation Research Initiative and the Biotechnology Industry Partnership Programme.

Rules for nanopharmaceuticals have been framed jointly by the Department of Biotechnology, the Indian Council of Medical Research and the Central Drugs Standard Control Organisation, covering the safety, quality and effect of such products. The minister said nanomedicine works at the scale of one-billionth of a metre and lets doctors treat patients differently according to genes, way of life, diet and surroundings. He cautioned that artificial intelligence and nanotechnology must support a doctor's clinical judgement rather than replace it, and called for medical teaching to be rethought without losing the old skills of observation and physical examination.